On average IHI researchers publish 10 scientific articles each month and these amount on average to over 100 scientific articles annually.
Published on: Feb. 18, 2026
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers
Jongo, S., Ackermann, E., Nyaulingo, G., Mbaraka, H., Reus, E., Cicconi, S., Saxena, M., Kassim, K., Tumbo, A., Rashid, M. A., Robinson, S., Louis, M., Satam, V., Rocha, F. B. D. S., Scandale, I., Assmus, F., Keiser, J., & Specht, S.
Antimicrobial Agents and Chemotherapy
Read article
Published on: Feb. 18, 2026
Individual and structural benefits, challenges, and strategies for integrating medication assistance treatment and antiretroviral services for persons living with HIV who use drugs in Dar es Salaam, Tanzania
Mushi, D., Sakejo, P., Somba, M., Huh, D., Rao, D., & Kaaya, S.
Research Square
Read article
Published on: Feb. 15, 2026
Semi-field evaluation of efficacy and residual activity of a microencapsulated pyriproxyfen formulation on Anopheles arabiensis emergence inhibition
Mutashobya, A., Mmbaga, A. T., Mnzava, S. T., Swai, H., Ngowo, H., & Lwetoijera, D. W.
MalariaWorld Journal
Read article
Published on: Feb. 15, 2026
Semi-field evaluation of efficacy and residual activity of a microencapsulated pyriproxyfen formulation on Anopheles arabiensis emergence inhibition
Mutashobya, A., Mmbaga, A. T., Mnzava, S. T., Swai, H., Ngowo, H., & Lwetoijera, D. W.
MalariaWorld Journal
Read article
Published on: Feb. 15, 2026
Repurposing Oxfendazole for Onchocerciasis: Population Pharmacokinetics of a Tablet Formulation in Healthy African Adults
Assmus, F., Adehin, A., Hoglund, R. M., Nyaulingo, G., Mbarak, H., Jongo, S., Ackermann, E., Reus, E., Keiser, J., Rocha, F. B. D. S., Specht, S., Scandale, I., & Tarning, J.
CPT: Pharmacometrics & Systems Pharmacology
Read article
Published on: Feb. 11, 2026
Species composition and blood feeding patterns of understudied Anopheles mosquitoes in southern Zambia, an area of low malaria transmission
Mudenda, T., Simubali, L., Mwaanga, G., Lubinda, M., Katowa, B., Musonda, M., Hamapumbu, H., Chibambo, P., Chooli, S., Ali, R. L. M. N., Gebhardt, M. E., Thuma, P. E., Simulundu, E., Moss, W. J., Saili, K., Norris, D. E., & Stevenson, J. C.
Malaria Journal
Read article
Published on: Feb. 3, 2026
Socioeconomic health equity with malaria burden: quantifying slope (Relative) index of inequity in malaria infection outcomes in the Southeastern-coastal Tanzania
Liu, L., Lu, S., Ding, W., Wang, Z., Abdulla, S., Lv, S., Li, S., Chaki, P. P., Zhou, X. N., Mlacha, Y. P., & Wang, D.
BMC Public Health
Read article
Published on: Feb. 2, 2026
Redefining the Wash Resistance Index to predict insecticidal durability of mosquito nets
Skovmand, O., Dang, D. M., Tran, T. Q., Bosselmann, R., & Moore, S. J.
MalariaWorld Journal
Read article
Published on: Feb. 2, 2026
Sublethal Pyriproxyfen Exposure Alters Anopheles arabiensis Fitness and Pyrethroid Susceptibility Without Trans-Generational Carry-Over
Mnzava, S. T., Mmbaga, A. T., Mutashobya, A., Muyaga, L. L., Mwema, M. F., Ngowo, H., & Lwetoijera, D. W.
Insects
Read article
Published on: Jan. 30, 2026
A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: a study protocol for open-label, randomized phase III trial (OptiRiMoxTB)
Mlyuka, H. J., Liyoyo, A., Nyaulingo, B., Mpolya, E., Kaswaga, O. L., Semvua, H., Lwambura, S., McHugh, T. D., Wildner, L., Sabiiti, W., Adegbite, B. R., Nliwasa, M., Khosa, C., Mbelele, P., Mbeya, B., Jeremiah, K., Boeree, M. J., Gillespie, S. H., Sloan, D. J., Mpagama, S. G., … SimpliciTB Consortium.
Trials
Read article
We're a Registered Charity Organization in Tanzania
Ifakara Health Institute (IHI) is officially recognized as a charitable organization under the Income Tax Act. Certification issued on 20 March 2025 and valid until 31 December 2030.
Ifakara Health Institute (IHI) is officially recognized as a charitable organization under the Income Tax Act. Certification issued on 20 March 2025 and valid until 31 December 2030.